Trial Profile
A Phase 1, Randomized, Open-label, Crossover, Drug Interaction Study Evaluating the Pharmacokinetic Profiles of Amoxicillin Administered Alone and in Combination With MMX Mesalazine/Mesalamine in Healthy Adult Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jun 2021
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary) ; Amoxicillin
- Indications Bacterial infections; Irritable bowel syndrome
- Focus Pharmacokinetics
- 30 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 01 Oct 2011 New trial record